5Wright C, Angus B, Nicholsons S, et al. Expression of c-erbB-2 oncoprotein: A prognostic indicator in human breast cancer. Cancer Res, 1989, 49(8): 2087-2090.
6Roetger A, Merschjann A, Dittmar T, et al. Selection of potentionally metastatic subpopulations expressing c-erbB-2 from breast cancer tissue by use of an extrevasation model. Am J Pathol, 1998, 153(6):1797 - 1806.
7Sauer T, Beraki K, Jebsen PW, et al. Numerical aberrations of chromosome 17 inter,phase cell nuclei of breast cancinoma cell: lack of correlation with abnormal expression of p53, neu and nm23 protein.APMIS, 1998, 106(10): 921-927.
8Mittra I, Radkar AA, Badwe B.A. Prognosis of breast cancer evidence for interaction between c-erbB-2 overpression and number of involved axillary lymph nodes. J Surg Oncol, 1995, 60(2): 106 - 111.
9McGuire WL, Clack GM. Prognostic factor and treatment decisions in axillary-node-negative breast cancer. N Engl J Med, 1992, 326(26):1756 - 1759.
10Dowsett M, Harper-Wynne C, Boeddinghaus I, et al. HER-2 amplification impedes the antiproliferative effects of hormone therapy in estrogen receptor-positive primary breast cancer. Cancer Res, 2001,61 (23): 8452 - 8458.
